Profile
Gonzalo de Miquel is currently a Member-Supervisory Board at Ventaleon GmbH since 2017.
Previously, he worked as Director-Global Clinical Development at Almirall SA, Independent Director at ALK-Abello A, and Vice President-Clinical Development at AstraZeneca PLC.
He also served as Chief Medical Officer & Executive VP-Development at Vectura Group Ltd.
from 2017 to 2020.
Gonzalo de Miquel active positions
| Companies | Position | Start |
|---|---|---|
Ventaleon GmbH
 Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany. | Director/Board Member | 2017-10-11 |
Former positions of Gonzalo de Miquel
| Companies | Position | End |
|---|---|---|
| VECTURA GROUP | Chief Tech/Sci/R&D Officer | 2020-02-29 |
| ALK-ABELLÓ A/S | Director/Board Member | - |
| ALMIRALL, S.A. | Corporate Officer/Principal | - |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| ALMIRALL, S.A. | Health Technology |
| ALK-ABELLÓ A/S | Health Technology |
| Private companies | 2 |
|---|---|
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Vectura Group Ltd. engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom. | Health Technology |
Ventaleon GmbH
Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany. | Health Technology |
- Stock Market
- Insiders
- Gonzalo de Miquel
